Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS)

Historical Holders from Q2 2016 to Q3 2025

Symbol
MRUS on Nasdaq
Type / Class
Equity / Common Shares, Euro 0.09 nominal value per share
Shares outstanding
75.9M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
69M
Holdings value
$6.5B
% of all portfolios
0.026%
Grand Portfolio weight change
0%
Number of holders
260
Number of buys
168
Number of sells
-112
Average Value change %
+0%
Average buys %
+0.014%
Average sells %
-0.009%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GENMAB A/S 94.8% $6.91B 71.9M Genmab A/S 12 Dec 2025
Paradigm Biocapital Advisors LP 6.2% +22% $440M $105M 4.67M +31.5% Paradigm BioCapital Advisors LP 30 Sep 2025
Commodore Capital LP 4.7% -13.3% $192M -$12.3M 3.53M -6% Commodore Capital LP 30 Jun 2025
FMR LLC 3.7% $262M 2.78M FMR LLC 30 Sep 2025
RTW INVESTMENTS, LP 2.7% $191M 2.03M RTW Investments, LP 30 Sep 2025
WELLINGTON MANAGEMENT GROUP LLP 0.6% -88% $43.2M -$308M 459K -87.7% Wellington Management Group LLP 30 Sep 2025

Institutional Holders of Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 69M $6.5B -$237M $94.15 260
2025 Q2 74.8M $3.93B +$216M $52.60 200
2025 Q1 70.8M $2.98B +$29.9M $42.09 185
2024 Q4 70.4M $2.96B -$77.8M $42.05 190
2024 Q3 69M $3.45B +$64.1M $49.96 186
2024 Q2 66.5M $3.94B +$944M $59.17 176
2024 Q1 51.2M $2.31B +$31M $45.03 155
2023 Q4 51.2M $1.41B +$91.1M $27.50 128
2023 Q3 47.5M $1.12B +$142M $23.58 112
2023 Q2 41.3M $1.09B +$133M $26.33 111
2023 Q1 36.5M $672M +$2.46M $18.40 103
2022 Q4 36.5M $565M -$17.8M $15.47 91
2022 Q3 34.4M $689M -$18.9M $20.03 100
2022 Q2 35M $793M +$42M $22.64 93
2022 Q1 33.2M $878M -$17.3M $26.44 94
2021 Q4 33M $1.05B +$313M $31.80 103
2021 Q3 22.2M $488M -$93.8M $22.00 63
2021 Q2 26.8M $564M +$1.61M $21.07 66
2021 Q1 26.7M $558M +$114M $20.89 58
2020 Q4 22M $387M +$58.5M $17.53 43
2020 Q3 18.2M $218M -$6.78M $12.00 41
2020 Q2 18.6M $299M +$19.4M $16.09 42
2020 Q1 18M $218M +$1.72M $12.10 29
2019 Q4 17.8M $251M +$61.1M $14.08 37
2019 Q3 11.9M $212M +$2.52M $17.82 26
2019 Q2 11.8M $173M -$427K $14.65 26
2019 Q1 11.9M $175M -$2.84M $14.77 24
2018 Q4 12.1M $169M -$3.57M $14.00 26
2018 Q3 12.1M $238M -$3.67M $19.74 29
2018 Q2 12.3M $280M +$31.2M $22.76 25
2018 Q1 9.8M $182M +$39M $18.53 20
2017 Q4 5.7M $111M -$2.56M $19.40 16
2017 Q3 5.83M $116M -$9.24M $19.87 16
2017 Q2 6.31M $100M -$1.17M $15.85 16
2017 Q1 6.34M $155M +$36M $24.38 22
2016 Q4 4.86M $103M +$3.57M $21.11 11
2016 Q3 4.7M $78.6M +$190K $16.75 12
2016 Q2 4.81M $38.6M +$38.6M $7.99 16